
Courtney Sanders’ Life Coaching Programs
Be wary of these life-changing claims.
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
Be wary of these life-changing claims.
Being part of The DunKings isn’t for the faint of heart – it takes commitment
TINA.org reader receives a suspicious email.
Six big game marketers that have been accused of fumbling ad claims.
This marketing may come with some baggage.